Clinical Trial Update: Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN